Transactions
Jul. 30, 2002
Latham Represents Amgen In Big Biotech Deal
The biggest merger in biotech history has closed, with Latham & Watkins representing Amgen Inc. in its $17.7 billion acquisition of Immunex Corp.
The biggest merger in biotech history has closed, with Latham & Watkins representing Amgen Inc. in its $17.7 billion acquisition of Immunex Corp.
Charles Ruck, the lead attorney for the deal, announced in December, says that many observers were surprised that a Los Angeles-based law firm, not a New York firm, was at the helm of such a hu...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In